Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 8
Submit an article Journal homepage
715
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Treatment strategies for myasthenia gravis

J Díaz-Manera Universitat Autònoma Barcelona, Hospital Santa Creu i Sant Pau, Neuromuscular Diseases Unit, Neurology Department, Av. Sant Antoni Maria Claret 167, 08025 Barcelona, Spain +34 93 556 5986; +34 93 556 5602; [email protected]
, MD,
R Rojas-García Universitat Autònoma Barcelona, Hospital Santa Creu i Sant Pau, Neuromuscular Diseases Unit, Neurology Department, Av. Sant Antoni Maria Claret 167, 08025 Barcelona, Spain +34 93 556 5986; +34 93 556 5602; [email protected]
, MD PhD &
Isabel Illa Universitat Autònoma Barcelona, Hospital Santa Creu i Sant Pau, Neuromuscular Diseases Unit, Neurology Department, Av. Sant Antoni Maria Claret 167, 08025 Barcelona, Spain +34 93 556 5986; +34 93 556 5602; [email protected]
, MD PhD
Pages 1329-1342 | Published online: 15 May 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jordi Díaz-Manera, Ricard Rojas García & Isabel Illa. (2012) Treatment strategies for myasthenia gravis: an update. Expert Opinion on Pharmacotherapy 13:13, pages 1873-1883.
Read now

Articles from other publishers (21)

Jintana B. Andersen, Nils Erik Gilhus & Donald B. Sanders. (2016) Factors affecting outcome in myasthenia gravis. Muscle & Nerve 54:6, pages 1041-1049.
Crossref
Anirban Gupta, Vinay Goyal, Achal Kumar Srivastava, Garima Shukla & Madhuri Behari. (2016) Remission And relapse of myasthenia gravis on long-term azathioprine: An ambispective study. Muscle & Nerve 54:3, pages 405-412.
Crossref
Marlies Keijzers, Peyman Sardari Nia & Jos G. Maessen. 2016. Core Topics in Thoracic Surgery. Core Topics in Thoracic Surgery 158 166 .
Yoshihisa Kadota, Hirotoshi Horio, Takeshi Mori, Noriyoshi Sawabata, Taichiro Goto, Shin-ichi Yamashita, Takeshi Nagayasu & Akinori Iwasaki. (2015) Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014. General Thoracic and Cardiovascular Surgery 63:4, pages 201-215.
Crossref
Jennifer L. Cruz, Marissa L. Wolff, Adam J. Vanderman & Jamie N. Brown. (2015) The emerging role of tacrolimus in myasthenia gravis. Therapeutic Advances in Neurological Disorders 8:2, pages 92-103.
Crossref
Ozlem Sahin & Alireza Ziaei. (2014) THE ROLE OF METHOTREXATE IN RESOLVING OCULAR INFLAMMATION AFTER SPECIFIC THERAPY FOR PRESUMED LATENT SYPHILITIC UVEITIS AND PRESUMED TUBERCULOSIS-RELATED UVEITIS. Retina 34:7, pages 1451-1459.
Crossref
Xin-Zheng CuiXin-Ying JiFeng Gao, Kun-Peng YangHui-Ling BaiMa Hong-BingTao LiQing-Yong Zhang. (2012) Evaluation of the New Classification and Surgical Strategy for Myasthenia Gravis. The American Surgeon 78:12, pages 1329-1335.
Crossref
E. Maruyama, N. Minami, M. Niino, N. Fujiki, S. Doi, M. Watanabe, K. Shima, S. Kikuchi & H. Sasaki. (2012) Impact of screening with thyroid ultrasonography in myasthenia gravis patients. Acta Neurologica Scandinavica 125:6, pages 398-402.
Crossref
C.-J. Liu, Y.-S. Chang, C.-J. Teng, T.-J. Chen, S.-M. Ou, C.-H. Tzeng & S.-J. Wang. (2012) Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population-based study. European Journal of Neurology 19:5, pages 746-751.
Crossref
Sivakumar Sathasivam & Andrew J. Larner. 2012. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine 769 778 .
Scott R. Haines & Matthew J. Thurtell. (2011) Treatment of Ocular Myasthenia Gravis. Current Treatment Options in Neurology 14:1, pages 103-112.
Crossref
J. Díaz-ManeraE. Martínez-HernándezL. QuerolR. KloosterR. Rojas-GarcíaX. Suárez-CalvetJ.L. Muñoz-BlancoC. MaziaK.R. StraasheijmE. GallardoC. JuárezJ.J. VerschuurenI. Illa. (2012) Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology 78:3, pages 189-193.
Crossref
Milan Blaha, Jiri Pitha, Vladimir Blaha, Miriam Lanska, Jaroslav Maly, Stanislav Filip, Miroslav Brndiar & Hana Langrova. (2011) Experience with extracorporeal elimination therapy in myasthenia gravis. Transfusion and Apheresis Science 45:3, pages 251-256.
Crossref
P. J. Chien, J. H. Yeh, H. C. Chiu, Y. M. Hsueh, C. T. Chen, M. C. Chen & C. M. Shih. (2011) Inhibition of peripheral blood natural killer cell cytotoxicity in patients with myasthenia gravis treated with plasmapheresis. European Journal of Neurology 18:11, pages 1350-1357.
Crossref
Ilkay Erdogan Orhan, Osman Üstün & Bilge Şener. (2011) Estimation of Cholinesterase Inhibitory and Antioxidant Effects of the Leaf Extracts of Anatolian Ficus carica var. domestica and their Total Phenol and Flavonoid Contents . Natural Product Communications 6:3, pages 1934578X1100600.
Crossref
Jee Young KimKee Duk ParkDavid P. Richman. (2011) Treatment of Myasthenia Gravis Based on Its Immunopathogenesis. Journal of Clinical Neurology 7:4, pages 173.
Crossref
Hyun Seok RohSang Yeul LeeJin Sook Yoon. (2011) Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis. Korean Journal of Ophthalmology 25:1, pages 1.
Crossref
Ippolit C. A. Matjucha. 2011. Evaluation and Management of Blepharoptosis. Evaluation and Management of Blepharoptosis 107 114 .
. (2010) Current World Literature. Current Opinion in Ophthalmology 21:6, pages 495-501.
Crossref
Maria Elena Farrugia & Angela Vincent. (2010) Autoimmune mediated neuromuscular junction defects. Current Opinion in Neurology 23:5, pages 489-495.
Crossref
M. Blaha, J. Pit'ha, V. Blaha, M. Lanska, J. Maly, S. Filip & H. Langrova. (2010) Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis. Journal of Biomedicine and Biotechnology 2010, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.